tirzepatide nejm π’ New in NEJM: π vs. Semaglutide π for obesity (no diabetes) π§ͺ 72-week RCT highlights: βοΈ Weight loss: β20.2% vs. β13.7% π Waist β: 18.4 cm vs. 13.0 cm π― More patients hit β₯25% lossβ¦ In patients with type 2
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 8 - Oct 13







:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)








,type=downsize)





